-- 
Viiv Withdraws U.S., EU Applications for Once-Daily Selzentry

-- B y   P h i l   S e r a f i n o
-- 
2011-09-20T09:36:28Z

-- http://www.bloomberg.com/news/2011-09-20/viiv-withdraws-u-s-eu-applications-for-once-daily-selzentry.html
Viiv Healthcare withdrew its
applications to U.S. and European regulators for the once-daily
HIV drug Selzentry, saying additional data is necessary to
establish the efficacy of once-daily dosing.  Viiv, a joint venture of  GlaxoSmithKline Plc (GSK)  and  Pfizer
Inc. (PFE) , commented in an e-mailed statement.  To contact the editor responsible for this story:
Phil Serafino at 
 pserafino@bloomberg.net  